Health Care

Share Mark as favorite


Two less-discussed issues tied to the King v. Burwell case involve federalism and the burden state governments would face if they decided not to establish their own Affordable Care Act-qualified health benefits exchanges, and the ability of future administrations to reinterpret the issue of tax credit subsidies in federal exchanges.

Share Mark as favorite

The Senate should reject new legislation that would use pay increases to coerce doctors to join Medicare ACOs.

Share Mark as favorite


The tobacco companies are no longer blowing smoke about the hazards of combusted-tobacco cigarettes. But the critics of electronic cigarettes — an important new technology that has the potential to replace smoking worldwide – have begun mass-producing doubt about the product.

Share Mark as favorite


The largest tax break in the federal tax code is a stealth subsidy that is both unfair and inefficient.

Share Mark as favorite


The pharmaceutical industry is perceived to be in a “productivity crisis” because research spending has grown rapidly, while the number of new FDA-approved molecules has remained relatively flat over time.

Share Mark as favorite


Myths about the ills of the private medical industry encourage bad policy such as product excise taxes, price controls, or weakened patent protection laws and compromise medical progress.

Share Mark as favorite


There are actually plenty of plans to replace Obamacare, some of which can be scientifically shown to be superior to Obamacare in terms of delivering on those promises. Isn’t it about time we gave such a plan a chance?

Share Mark as favorite


By operating under the myth that commercial ties are inevitably corrupting, the FDA sealed itself off from a group of scientists whose knowledge and perspectives are critical to the development of wise tobacco regulation.

Share Mark as favorite


Separate simulations by the Urban Institute and the Rand Corporation predict that “adverse selection,” where healthier people leave the insurance market and sicker people stay in causing premiums to rise, will occur if the King plaintiffs prevail. Despite these forecasts, historical studies indicate that a death spiral will not occur.

Share Mark as favorite


Scott Gottlieb addressed the Attorneys General Education Program Public Policy Conference on Federalism and the Pharmaceutical Industry March 26, 2015.

Sort By:

Refine Content:

Additional Keywords:

Refine Results

or to save searches.

Refine Content